OLP patient characteristics
Diabetes mellitus- Thyroid disease-, thyroid disease, Anti-dyslipidemia, Lips- Labial mucosa- Buccal mucosa-, palate, diabetic, hypertensive, OLP, gout, hypertension, dyslipidemia
THYROID DISEASE, DYSLIPIDEMIA, DIABETES MELLITUS, CAVITY, HYPERTENSION, FLOOR OF MOUTH, ULCERATION, GOUT, HYPERTENSION, DISEASES, DYSLIPIDEMIA
The 72 patients (100% response rate) in this study consisted of 59 women (81.9%) and 13 men (18.1%). The mean age of the patients in this study was 53.3 ± 12.4 years old (range 22–81 years old). Forty-six patients (63.9%) were between 30 and 60 years old. Twenty-three patients (31.9%) were more than 60 years old and 3 patients (4.2%) were less than 30 years old. Fifty-one patients (70.8%) had their OLP less than 1 year before seeing the dentists, however, 14 patients (19.4%) were diagnosed 1–3 years earlier. Seven patients (9.8%) had their lesions for more than 3 years. The mean duration of OLP was 21.3 ± 30.1 months (range 1–120 months).Regarding patients’ systemic conditions, 40 patients (55.6%) reported no medical problem and were not taking any medication. Twenty-two patients (30.6%) were diagnosed as dyslipidemia and took anti-dyslipidemia drugs (e.g. simvastatin, rosuvastatin, etc.) Furthermore, 20 (27.8%) of the patients had hypertension and 9 (12.5%) had diabetes mellitus. Both diseases required more than one group of drugs, namely, 27 patients (37.5%) required hypertensive drugs (e.g. amlodipine, atenolol, enalapril etc.) and 13 patients (18.1%) required diabetic drugs (e.g. metformin, glipizide, etc.). Four patients (5.6%) with thyroid disease and 2 patients (2.8%) with gout had taken levothyroxine and allopurinol, respectively.Some patients reported more than one chief complaint at the first visit. Common chief complaints were burning sensation (80.6%), ulceration (65.3%), and rough oral mucosal surface (19.4%). One patient had no symptom (1.4%). Sixty patients (83.3%) were new patients and 12 patients (16.7%) were follow-up patients.OLP occurred in various sites in the oral cavity, with the most commonly affected area being the buccal mucosa (80.6%) followed by gingiva (76.4%), tongue (18.1%), lips (16.7%), and floor of the mouth (11.1%). Less than 10% of the patients demonstrated OLP at the palate (6.9%) and labial mucosa (5.6%).The most frequently prescribed topical corticosteroids were 0.1% fluocinolone acetonide in orabase (37.5%), followed by 0.05% dexamethasone mouthwash (31.9%), 0.1% triamcinolone mouthwash (16.6%) and 0.05% fluocinolone mouthwash (15.3%). Other topical corticosteroids, 0.05% clobetasol propionate in orabase (2.8%) and 0.1% fluocinolone solution (1.4%), were infrequently prescribed. (Table 
Baseline characteristics and clinical data of the OLP patients (N = 72)- Women- Men59 (81.9)13 (18.1)- None- Dyslipidemia- Hypertension- Diabetes mellitus- Thyroid disease- Gout40 (55.6)22 (30.6)20 (27.8)9 (12.5)4 (5.6)2 (2.8)- None- Anti-dyslipidemia drugs- Anti-hypertensive drugs- Anti-diabetic drugs- Levothyroxine- Allopurinol40 (55.6)22 (30.6)27 (37.5)13 (18.1)4 (5.6)2 (2.8)- Burning sensation- Ulceration- Roughness- No symptoms58 (80.6)47 (65.3)14 (19.4)1 (1.4)- New patients- Follow-up patients60 (83.3)12 (16.7)- Lips- Labial mucosa- Buccal mucosa- Gingiva- Tongue- Floor of mouth- Palate12 (16.7)4 (5.6)58 (80.6)55 (76.4)13 (18.1)8 (11.1)5 (6.9)- 0.1% Fluocinolone acetonide in orabase- 0.05% Clobetasol propionate in orabase- 0.05% Dexamethasone mouthwash- 0.1% Triamcinolone mouthwash- 0.05% Fluocinolone mouthwash- 0.1% Fluocinolone solution27 (37.5)2 (2.8)23 (31.9)12 (16.6)11 (15.3)1 (1.4)